Home
|
Continuing Education Activities
Enduring
Live
Documents & Forms
|
Regularly Scheduled Series
Documents & Forms
|
Resources
|
About Us
Contact
Mission Statement
Letter From Vic Hatcher
|
FAQ
Optimizing the Use of BTK Inhibition in CLL: How Do You ...
Activity Name
Optimizing the Use of BTK Inhibition in CLL: How Do You Choose?
Activity Directors
Noah Kornblum, MD
Activity Specialties
ONCOLOGY
Topic
Chronic Lymphocytic Leukemia
Activity Dates and Expiration
Begins:
June 24, 2023
Ends:
June 24, 2023
Activity Credits:
0.00
Login as Existing User
Email Address
*
Password
*
Remember me
|
Forgot password?
My Profile
|
Logout